Literature DB >> 22869608

Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children.

Nina Alexander1, Franziska Rosenlöcher, Tobias Stalder, Julia Linke, Wolfgang Distler, Joachim Morgner, Clemens Kirschbaum.   

Abstract

CONTEXT: Antenatal glucocorticoid (GC) exposure has been discussed as a potent programming factor of hypothalamus-pituitary-adrenal (HPA) axis activity, producing sustained alterations in cortisol secretion throughout life. So far, the assessment of HPA-axis activity in offspring of mothers treated with synthetic GC has been limited to a time period shortly after birth, with prematurity being an important confound in most prior studies.
OBJECTIVE: The present study aimed to investigate HPA-axis reactivity of term-born children with antenatal GC exposure in a larger sample, allowing us to further address sex- and drug-specific effects. DESIGN, SETTING, AND PARTICIPANTS: This was a cross-sectional study comprised of 209 term-born children between 6 and 11 yr of age. Cortisol secretion patterns in response to a standardized laboratory stressor (Trier Social Stress Test for Children) were assessed in children with antenatal GC exposure (a single course of either dexamethasone or betamethasone) and compared to different control groups.
RESULTS: We observed significantly increased cortisol reactivity to acute psychosocial stress in 6- to 11-yr-old, term-born children exposed to antenatal synthetic GC treatment compared to controls (F(3.4,345.9)=5.8; P<0.001). This finding appeared to be independent of the specific synthetic GC used and was found to be more pronounced in females.
CONCLUSIONS: The present study provides the first evidence for long-lasting effects of antenatal synthetic GC exposure on HPA-axis reactivity in term-born children. These findings may bear important implications regarding the vulnerability for stress-related physical and psychiatric disorders, for which dysregulation of the HPA-axis has been discussed as a potential causal factor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22869608     DOI: 10.1210/jc.2012-1970

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  51 in total

1.  Antenatal glucocorticoid treatment is associated with diurnal cortisol regulation in term-born children.

Authors:  M N Edelmann; C A Sandman; L M Glynn; D A Wing; E P Davis
Journal:  Psychoneuroendocrinology       Date:  2016-06-23       Impact factor: 4.905

Review 2.  Glucocorticoid receptor signaling in health and disease.

Authors:  Mahita Kadmiel; John A Cidlowski
Journal:  Trends Pharmacol Sci       Date:  2013-08-14       Impact factor: 14.819

Review 3.  How the kidney is impacted by the perinatal maternal environment to develop hypertension.

Authors:  Ana D Paixão; Barbara T Alexander
Journal:  Biol Reprod       Date:  2013-12-19       Impact factor: 4.285

4.  Can Placental Corticotropin-Releasing Hormone Inform Timing of Antenatal Corticosteroid Administration?

Authors:  Danielle A Swales; Leah A Grande; Deborah A Wing; Michelle Edelmann; Laura M Glynn; Curt Sandman; Roger Smith; Maria Bowman; Elysia Poggi Davis
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

5.  Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation.

Authors:  Popi Sifianou; Voula Thanou; Helen Karga
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Mar-Apr

Review 6.  Does Prenatal Maternal Distress Contribute to Sex Differences in Child Psychopathology?

Authors:  Laurel M Hicks; Danielle A Swales; Sarah E Garcia; Camille Driver; Elysia Poggi Davis
Journal:  Curr Psychiatry Rep       Date:  2019-02-07       Impact factor: 5.285

7.  Endocrine disorders in pregnancy: stress responses in children after maternal glucocorticoids.

Authors:  John R G Challis
Journal:  Nat Rev Endocrinol       Date:  2012-10-02       Impact factor: 43.330

Review 8.  Glucocorticoids and fetal programming part 1: Outcomes.

Authors:  Vasilis G Moisiadis; Stephen G Matthews
Journal:  Nat Rev Endocrinol       Date:  2014-05-27       Impact factor: 43.330

Review 9.  Minireview: the impact of antenatal therapeutic synthetic glucocorticoids on the developing fetal brain.

Authors:  Melanie E Peffer; Janie Y Zhang; Leah Umfrey; Anthony C Rudine; A Paula Monaghan; Donald B DeFranco
Journal:  Mol Endocrinol       Date:  2015-03-12

Review 10.  Antenatal endogenous and exogenous glucocorticoids and their impact on immune ontogeny and long-term immunity.

Authors:  María Emilia Solano; Megan C Holmes; Paul R Mittelstadt; Karen E Chapman; Eva Tolosa
Journal:  Semin Immunopathol       Date:  2016-07-28       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.